Financials
- Market Capitalization 140.43 M
- Employee 64
- Founded 2012
- CEO N/A
- Website www.connectbiopharm.com
- Headquarter Cayman Islands
- FIGI BBG00ZGYNJ49
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3772 | ADCT ADC Therapeutics SA Common Shares | 1.14 USD | +1.79% | +14.00% | +0.88% | -63.11% | 145.54 M USD | ||
| 3776 | MIST Milestone Pharmaceuticals Inc. - Common Shares | 1.16 USD | -2.52% | +9.43% | +11.54% | -36.96% | 144.42 M USD | ||
| 3813 | HURA TuHURA Biosciences, Inc. - Common Stock | 2.11 USD | -0.94% | +0.48% | 0.00% | -21.56% | 134.46 M USD | ||
| 3818 | INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.29 USD | +2.38% | +8.40% | +76.71% | -45.11% | 133.38 M USD |
Frequently asked questions about Connect Biopharma Holdings Limited Ordinary Shares
What is the Connect Biopharma Holdings Limited Ordinary Shares stock price today?
The current price of Connect Biopharma Holdings Limited Ordinary Shares (CNTB) is 2.23. Over the past 24 hours, the stock has changed by -2.19%. Follow the CNTB chart for real-time price dynamics.
What is the stock ticker of Connect Biopharma Holdings Limited Ordinary Shares?
Connect Biopharma Holdings Limited Ordinary Shares trades under the ticker CNTB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Connect Biopharma Holdings Limited Ordinary Shares stock going up?
CNTB has changed by -5.51% over the last week, +8.78% over the last month, and +8.78% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Connect Biopharma Holdings Limited Ordinary Shares?
Connect Biopharma Holdings Limited Ordinary Shares currently has a market capitalization of 140.43 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Connect Biopharma Holdings Limited Ordinary Shares earnings last quarter?
Last quarter, Connect Biopharma Holdings Limited Ordinary Shares reported earnings of -0.27 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Connect Biopharma Holdings Limited Ordinary Shares revenue for the last quarter?
Connect Biopharma Holdings Limited Ordinary Shares reported quarterly revenue of 2.77 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Connect Biopharma Holdings Limited Ordinary Shares net income for the last quarter?
Connect Biopharma Holdings Limited Ordinary Shares reported net income of -17.28 M for the last quarter. The previous quarter showed -19.4 M, which means net income changed by +10.90%.
How many employees does Connect Biopharma Holdings Limited Ordinary Shares have?
As of the latest available data, Connect Biopharma Holdings Limited Ordinary Shares has 64 employees. Workforce size can provide additional context about the company's scale and operations.
What is Connect Biopharma Holdings Limited Ordinary Shares EBITDA?
Connect Biopharma Holdings Limited Ordinary Shares EBITDA is -17.44 M, and its EBITDA margin is -630.17%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Connect Biopharma Holdings Limited Ordinary Shares stock?
You can buy Connect Biopharma Holdings Limited Ordinary Shares (CNTB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Connect Biopharma Holdings Limited Ordinary Shares stock?
Investing in Connect Biopharma Holdings Limited Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CNTB chart and related analysis on metatrader.com as part of your research.